Sucratas-O Oral Suspension
By Sucratas-O
Rx
100ml Oral Suspension in a Bottle

Composition
Sucralfate(1gm/5ml) + Oxetacaine(10mg)

Manufacturer - Intas Pharmaceuticals Ltd
Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Expires on or after
August, 2025

liver
When using Sucratas-O Oral Suspension, it is important to exercise caution if you have a history of liver disease or conditions. Limited information is available on its use in patients with liver disease, so it is crucial to consult your doctor before taking this medication. Your doctor may need to adjust the dose accordingly to ensure your safety and well-being.

kidney
Sucratas-O Oral Suspension should be used with caution in patients with kidney disease. Due to the presence of aluminium in Sucratas-O Oral Suspension, which is eliminated by the kidneys, individuals with kidney issues may face increased risk of aluminium toxicity. Dosage adjustment may be required for kidney disease patients. Please consult your doctor.

alcohol
Caution is recommended when drinking alcohol with Sucratas-O Oral Suspension as it can lead to dehydration and increase stomach acid, potentially reducing the effectiveness of the suspension. Consulting your doctor is advised.

driving
When taking Sucratas-O Oral Suspension, be cautious as it may reduce alertness, impact vision, and cause drowsiness or dizziness. If experiencing these symptoms, refrain from driving.

pregnancy
It is better to consult your doctor before using Sucratas-O Oral Suspension during pregnancy. Your doctor will assess the benefits and risks before prescribing it.

breastfeeding
It is better to consult your doctor before using Sucratas-O Oral Suspension.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | - |
₹168
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 11-Feb-2025